SV2A PET imaging, now at its early discovery phase, is expected to provide further important information on synaptic protein alterations, along with other pathological changes, during the entire AD progression continuum, and contribute to the early detection of the disease. The gene discussed is SV2A; the disease is Alzheimer disease.